No Data
No Data
No Data
No Data
No Data
Iris Acquisition on Pace for Largest Percent Decrease Since June 2021 -- Data Talk
Iris Acquisition Corp Class A (IRAA) is currently at $10.05, down $0.33 or 3.18% --Would be lowest close since Jan. 4, 2023, when it closed at $10.05 --On pace for largest percent decrease since Jun
Dow JonesFeb 28, 2023 00:33
Program CD47, Provided the CMC Service by GenScript ProBio to InnobationBio, Will Further Be Advanced by the Joint Venture Between Liminatus Pharma LLC and Iris Acquisition Corp
PRNewswireDec 5, 2022 20:05
Iris Acquisition, Liminatus Pharma Sign SPAC Merger Deal
04:18 AM EST, 12/01/2022 (MT Newswires) -- Iris Acquisition Corp. (IRAA), a blank-check firm, and clinical-stage biopharmaceutical company Liminatus Pharma said late Wednesday that they have reached a
MT NewswiresDec 1, 2022 17:20
Liminatus Transaction Is Expected to Close in 1H 2023 >IRAA
Liminatus Transaction Is Expected to Close in 1H 2023 >IRAA
Dow JonesDec 1, 2022 10:00
Combined Company Is Expected to Be Listed on Nasdaq Capital Market, Renamed Liminatus Pharma Inc >IRAA
Combined Company Is Expected to Be Listed on Nasdaq Capital Market, Renamed Liminatus Pharma Inc >IRAA
Dow JonesDec 1, 2022 09:59
Transaction Values Combined Companies at Pro Forma Enterprise Value of $334M >IRAA
Transaction Values Combined Companies at Pro Forma Enterprise Value of $334M >IRAA
Dow JonesDec 1, 2022 09:58
No Data
No Data